Stemline Therapeutics Stock Price - STML

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 7.03 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Stemline Therapeutics Inc STML NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 7.03 7.39 6.94 7.14 7.03 23:59:38
Bid Price Ask Price Spread Spread % News
6.56 7.44 0.88 11.83% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
8,391 1,317,995 $ 7.16 $ 9,437,154 917,357 6.01 - 18.22
Last Trade Time Type Quantity Stock Price Currency
17:58:57 2 $ 7.04 USD

Stemline Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 352.41M 50.13M $ -85.02M -3.00 - 46.11M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Stemline Therapeutics News

Loading Messages....

Latest STML Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical STML Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week10.2810.3046.016.863,199,206-3.25-31.61%
1 Month10.4411.456.017.831,134,426-3.41-32.66%
3 Months9.5411.456.018.89704,072-2.51-26.31%
6 Months13.0218.226.0110.52667,359-5.99-46.01%
1 Year10.0218.226.0111.64605,310-2.99-29.84%
3 Years12.9520.555.5011.92396,045-5.92-45.71%
5 Years14.9520.553.8811.67283,959-7.92-52.98%

Stemline Therapeutics Description

Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is involved in the business of discovering, acquiring and developing and commercializing therapeutics for oncology indications of unmet medical need. It is developing clinical stage product candidates namely SL-401, SL-801, and SL-701. The company is also involved in advancing its clinical stage programs, expanding and strengthening its intellectual property portfolio, identifying and acquiring additional product and technology rights.

Your Recent History
Stemline T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.